Earnings Feed
Start Free
Home/Filings/4/0001140361-15-001481
4//SEC Filing

REXAHN PHARMACEUTICALS, INC. 4

Accession 0001140361-15-001481

$IRDCIK 0001228627operating
View on SEC.govCompany Profile

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 6:11 PM ET

Size

20.6 KB

Accession

0001140361-15-001481

Insider Transaction Report

Form 4
Period: 2015-01-08
REXAHN PHARMACEUTICALS, INC.RNN
Ahn Chang Ho
DirectorChairman & CEO
Transactions
  • Sale

    Common Stock

    2015-01-08$0.90/sh−80,000$72,032→ 6,010,000 total
  • Sale

    Common Stock

    2015-01-09$0.92/sh−186,212$170,477→ 6,010,000 total
  • Exercise/Conversion

    Common Stock

    2015-01-12$0.80/sh+48,444$38,755→ 6,058,444 total
  • Exercise/Conversion

    Stock Option (right to purchase)

    2015-01-12−48,444→ 549,151 total
    Exercise: $0.80Exp: 2015-01-20→ Common Stock (48,444 underlying)
  • Exercise/Conversion

    Stock Option (right to purchase)

    2015-01-09−186,212→ 597,595 total
    Exercise: $0.80Exp: 2015-01-20→ Common Stock (186,212 underlying)
  • Exercise/Conversion

    Common Stock

    2015-01-08$0.80/sh+80,000$64,000→ 6,090,000 total
  • Exercise/Conversion

    Common Stock

    2015-01-09$0.80/sh+186,212$148,970→ 6,196,212 total
  • Sale

    Common Stock

    2015-01-12$0.91/sh−48,444$44,263→ 6,010,000 total
  • Exercise/Conversion

    Stock Option (right to purchase)

    2015-01-08−80,000→ 783,807 total
    Exercise: $0.80Exp: 2015-01-20→ Common Stock (80,000 underlying)
Holdings

  • Common Stock

    (indirect: By Spouse)
    500,000
Footnotes (6)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]The price of $0.9004 per share represents a weighted average of sales prices from $0.90 to $0.9098 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]The price of $0.9155 per share represents a weighted average of sales prices from $0.90 to $0.945 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F4]The price of $0.9137 per share represents a weighted average of sales prices from $0.90 to $0.9351 per share. The reporting person undertakes to provide upon request of the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F5]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F6]Options vested and became exercisable based on the following schedule: 300,000 on January 20, 2006, 300,000 on January 20, 2007, and 400,000 on January 20, 2008.

Documents

1 file

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001228627

Filing Metadata

Form type
4
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 6:11 PM ET
Size
20.6 KB
View on SEC.gov